Login / Signup

Work productivity in rheumatoid arthritis patients from two Latin American countries treated with tofacitinib or biological DMARDs.

Magda V Gutierrez-ArdilaJuan Manuel Reyes-SanchezH MadariagaW OteroR GuzmanJ IzquierdoM AbelloP VelezD CastilloDario Ponce de LeonT LukicL Amador
Published in: Expert review of pharmacoeconomics & outcomes research (2022)
NCT03073109.
Keyphrases
  • rheumatoid arthritis patients
  • disease activity
  • rheumatoid arthritis
  • climate change
  • ulcerative colitis
  • newly diagnosed